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Introduction: Limited data is available on outcomes with renal
denervation (RDN) in an Indian patient population. The Single-arm
Study of SymplicityTM Renal Denervation System in Patients With
Uncontrolled HyperTensioN in India (HTN-India) study prospec-
tively evaluated the safety and efﬁcacy of renal denervation ther-
apy in an Indian population with uncontrolled hypertension using
the Symplicity FlexTM catheter (Medtronic, Inc.).
Material: The primary effectiveness endpoint is 6-month change in
ofﬁce systolic blood pressure (SBP). Home BP was also recorded at
baseline and 6 months.
Observations and conclusions: A total of 28 subjects at 7 sites were
consented and 14 subjects were treated with RDN in HTN-India
when the study was stopped following the announcement of
results of the SYMPLICITY HTN-3 trial. Baseline ofﬁce and home
SBP was 177  17 and 160  11 mmHg; average age was 51  11
years, 57% were male, 21% had type II diabetes, and average body
mass index was 28  5 kg/m2. Subjects were prescribed 4.1  1.2
and 4.5  1.1 antihypertensive medications at baseline and 6
months. Both ofﬁce and home SBP decreased signiﬁcantly at 6
months (28.5  23.8 mmHg, and 19.6  13.6 mmHg, respec-
tively, p ≤ 0.01 for both). No procedure-related adverse events were
reported, although there was one non-cardiovascular death
(severe burn unrelated to RDN) at 5 months. We conclude that
RDN was safe and effective in this Indian population with treat-
ment resistant hypertension. Conﬁrmatory prospective sham con-
trolled trials are warranted.
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Objectives:
Primary: To study the association between central aortic blood
pressure indices and coronary artery disease in patients under-
going elective angiography.
Secondary: (a) To study whether any association exists between
central aortic pressure indices and the incidence of major adverse
cardiovascular events (MACE) in the same patients during a 6-
month follow up period. (b) To study whether any association
exists between the central aortic pressures and peripheral pres-
sures.
Methods:We conducted a prospective observational study in con-
secutive patients undergoing coronary angiography. Central and
peripheral pressures were invasively recorded and coronary artery
disease (CAD) classiﬁed into obstructive and non-obstructive
group. CAD severity was graded using the Gensini score and sub-
jects were divided into tertiles. Patients were followed up and the
role of central aortic pressure indices in the prediction of cardio-
vascular events were analyzed.
Results: A total of 623 patients were enrolled. Central pulsatility
was found to increase across the ﬁrst 2 Gensini tertiles with a
decrease in the third tertile, probably a reﬂection of increasing age.
No signiﬁcant association was noted between the central aortic
pressures and MACE, with short follow up time being a major
limitation. A positive correlation was found between the central
and peripheral mean pressures and pulse pressures.
Conclusions:Of the various central aortic pressure indices studied,
central pulsatility was found to most closely associated with the
severity of CAD. Studies with longer follow up are needed to assess
the deﬁnite role of central aortic pressure indices with cardiovas-
cular outcomes.
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Background: Orthostatic hypertension is deﬁned as an increase in
blood pressure upon assuming an upright posture.
Method: Over the last 4 years, 50 patients with average age
between 50 and 70 years and with long standing hypertension
and diabetes (>10 years) complained of uncontrolled hypertension
with more than 2 antihypertensives including one diuretic plus
ARBs, ACEIs, B blockers and calcium channel and B blockers in
various combinations and optimal tolerated doses, poorly con-
trolled diabetes.
And symptom of intense throbbing headache which worsened on
sitting or standing from supine posture and got relieved partially
on lying down. BP of all those patients were found to be signiﬁ-
cantly higher on sitting and standing. All patientswere initially put
on 24 h ambulatory BP monitoring. All were found to have sig-
niﬁcantly higher sitting and standing BP. Patients were then
screened for all causes of secondary hypertension. CT brain was
done to rule out neurological cause of headache. Finally,minimally
invasive hemodynamic monitoring was done.
Result: Lab reports showed an average HbAIC 7.5–8.0, GFR of 50–
60 ml/min/1.73 m2. Hemodynamic monitoring revealed marked
raised systemic vascular resistance (SVR) suggestingmarked alpha
adrenergic receptor hypersensitivity. Patients responded to cen-
trally acting sympatholytic drug clonidine and alpha antagonist
prazocin.
Conclusion: Orthostatic hypertension if diagnosed accurately can
be successfully treated with central sympatholytics and alpha
antagonists with good BP control, reduction of postural variation
of BP, and loss of symptoms.
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Background: Hypertension remains the most common, readily
identiﬁable, and reversible risk factor for various cardiovascular
diseases. ABPM has advantages compared to ofﬁce BP and
is mainly used to diagnose white coat hypertension, masked
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hypertension, and nocturnal hypertension which have adverse
cardiovascular outcomes.
Aims and objectives: (1) To evaluate in diagnosed hypertensive
patients of prevalence of white coat hypertension, masked hyper-
tension, dipping status, white coat effect, resistant hypertension,
hypotensive episodes and diurnal variation of blood pressure. (2)
To study co-morbidities, markers of end organ damage and efﬁ-
cacy of anti-hypertensive regimen.
Material and methods: This is a single center prospective observa-
tional study. Total of 360 hypertensive patients with predecided
inclusion and exclusion criteria were enrolled in this study and
ABPM was performed on them by admitting them for one day.
Results: In this study, mean patient age was 53 years and majority
(75.6%) were males. Mean BMI was 24.94  4.47 kg/m2. The
prevalence of white coat hypertension was 39.7% and masked
hypertension was 17.5%. In this study, 30.1% had pseudo
resistant hypertension/white coat effect and 69.9% subjects had
true resistant hypertension. Amongst hypertensive patients on
treatment, prevalence of non-dippers was 46.7%, reverse dippers
(risers) was 16.7%, and extreme dippers was 0.6%. Mean 24 h
average heart rate was 74.11  11.45. Associated co-morbidities
were diabetes in 28.6%, ischemic heart disease in 36.9%, peripheral
vascular disease in 3.1%, stroke in 3.9%, CKD in 4.4% of patients.
21.7% patients had evidence of LVH in ECG and 35.6% had evidence
of LVH in echocardiogram. 12.8% subjects had albuminuria. Most
common group of anti-hypertensive drug was CCB in 55% of
patients followed by Beta blockers in 51.3% and ARB in 34.4%.
Conclusion: ABPM should be used in hypertensive patients to
diagnose white coat hypertension, masked hypertension, drug
resistant hypertension, night time dipping status of blood pres-
sure,monitoring the efﬁcacy of anti-hypertensive drugs, 24 h blood
pressure variability. Nocturnal hypertension (non dippers) is
related to adverse cardiovascular outcomes and can only be mea-
sured by ABPM or home blood pressure monitoring.
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